Shares of Gilead Sciences Inc. (NASDAQ: GILD), a research-based biopharmaceutical company engaged in the discovery, development and commercialization of medicines, are seeing a huge rally in early trading today. At last check, GILD shares were trading 12.08% higher at $72.86 on above average volume of 10.39 million. The stock hit a 52-week high of $73.25 [...]
Recent Comments